CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,190,727 | +442.4% | 1,533,969 | +500.6% | 0.09% | +475.0% |
Q2 2023 | $8,330,887 | -68.2% | 255,392 | -65.7% | 0.02% | -71.4% |
Q1 2023 | $26,227,353 | -43.4% | 745,307 | -26.3% | 0.06% | -46.2% |
Q4 2022 | $46,345,189 | +0.1% | 1,011,462 | +5.8% | 0.10% | +3.0% |
Q3 2022 | $46,313,000 | -12.9% | 955,886 | -29.4% | 0.10% | -7.3% |
Q2 2022 | $53,164,000 | +4571.7% | 1,353,137 | +4278.4% | 0.11% | +5350.0% |
Q1 2022 | $1,138,000 | -43.5% | 30,905 | -30.0% | 0.00% | -50.0% |
Q4 2021 | $2,014,000 | -23.2% | 44,171 | -66.7% | 0.00% | -66.7% |
Q2 2021 | $2,622,000 | -58.8% | 132,497 | -51.6% | 0.01% | -58.6% |
Q1 2021 | $6,371,000 | +486.6% | 273,906 | +423.9% | 0.03% | +383.3% |
Q4 2020 | $1,086,000 | -75.8% | 52,278 | -74.8% | 0.01% | -79.3% |
Q3 2020 | $4,491,000 | +3354.6% | 207,453 | +1197.2% | 0.03% | +2800.0% |
Q1 2019 | $130,000 | +154.9% | 15,992 | +100.0% | 0.00% | 0.0% |
Q4 2018 | $51,000 | -76.8% | 7,996 | -73.9% | 0.00% | -88.9% |
Q1 2018 | $220,000 | – | 30,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |